240 related articles for article (PubMed ID: 12715326)
1. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome.
Kerr JR; Cunniffe VS; Kelleher P; Bernstein RM; Bruce IN
Clin Infect Dis; 2003 May; 36(9):e100-6. PubMed ID: 12715326
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome.
Attard L; Bonvicini F; Gelsomino F; Manfredi R; Cascavilla A; Viale P; Varani S; Gallinella G
J Clin Virol; 2015 Jan; 62():54-7. PubMed ID: 25542471
[TBL] [Abstract][Full Text] [Related]
3. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
Seishima M; Mizutani Y; Shibuya Y; Arakawa C
Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
[TBL] [Abstract][Full Text] [Related]
4. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
[TBL] [Abstract][Full Text] [Related]
5. A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists.
Lowry SM; Brent LH; Menaldino S; Kerr JR
Clin Infect Dis; 2005 Aug; 41(4):e42-4. PubMed ID: 16028146
[TBL] [Abstract][Full Text] [Related]
6. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
[TBL] [Abstract][Full Text] [Related]
8. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
Kerr JR; Gough J; Richards SC; Main J; Enlander D; McCreary M; Komaroff AL; Chia JK
J Gen Virol; 2010 Apr; 91(Pt 4):893-7. PubMed ID: 20007355
[TBL] [Abstract][Full Text] [Related]
9. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
10. Pancreas allograft thrombosis following intravenous immunoglobulin administration to treat parvovirus B19 infection.
Muthusamy AS; Vaidya AC; Sinha S; Atabani SF; Haque T; Jones G; Cunningham J; Friend PJ
Transpl Infect Dis; 2009 Oct; 11(5):463-6. PubMed ID: 19594866
[TBL] [Abstract][Full Text] [Related]
11. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
Kerr JR; Cunniffe VS; Kelleher P; Coats AJ; Mattey DL
J Med Virol; 2004 Sep; 74(1):147-55. PubMed ID: 15258981
[TBL] [Abstract][Full Text] [Related]
12. Increase in B19 viral load prior to relapse of anaemia in an AIDS patient with persistent B19 infection.
Hung CC; Lee KL; Chen MY
J Infect; 2001 Aug; 43(2):150-2. PubMed ID: 11676524
[TBL] [Abstract][Full Text] [Related]
13. Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.
Katragadda L; Shahid Z; Restrepo A; Muzaffar J; Alapat D; Anaissie E
Transpl Infect Dis; 2013 Aug; 15(4):354-60. PubMed ID: 23578205
[TBL] [Abstract][Full Text] [Related]
14. Preexisting psychological stress predicts acute and chronic fatigue and arthritis following symptomatic parvovirus B19 infection.
Kerr JR; Mattey DL
Clin Infect Dis; 2008 May; 46(9):e83-7. PubMed ID: 18419428
[TBL] [Abstract][Full Text] [Related]
15. Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection.
Guillaume MP; Hermanus N; Peretz A
Clin Rheumatol; 2002 Aug; 21(4):306-8. PubMed ID: 12189459
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with high-dose intravenous immunoglobulin for parvovirus b19 infection associated with acute fulminant hepatitis in a chinese child.
Cao YH; Zhang GY; Zhang GC
Clin Pediatr (Phila); 2009 Jul; 48(6):674-6. PubMed ID: 19286620
[No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
Mouthon L; Guillevin L; Tellier Z
Autoimmun Rev; 2005 Jun; 4(5):264-9. PubMed ID: 15990072
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in parvovirus B19 infection as an aid to understanding chronic fatigue syndrome.
Kerr JR; Tyrrell DA
Curr Pain Headache Rep; 2003 Oct; 7(5):333-41. PubMed ID: 12946285
[TBL] [Abstract][Full Text] [Related]
19. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.
Renoult E; Bachelet C; Krier-Coudert MJ; Diarrassouba A; André JL; Kessler M
Transplant Proc; 2006 Sep; 38(7):2321-3. PubMed ID: 16980079
[TBL] [Abstract][Full Text] [Related]
20. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection.
Tang JW; Lau JS; Wong SY; Cheung JL; Chan CH; Wong KF; Wong A; Chan PK
J Med Virol; 2007 Sep; 79(9):1401-5. PubMed ID: 17607784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
